Rutherford, NJ, – Cancer Genetics, Inc. (CGI) a leader in cancer diagnostics announces that it has been selected by Roche Servicios S.A., an affiliate of the Swiss drug maker Roche based in Costa Rica, as its partner for cancer testing. Under this service agreement, CGI performs highly complex testing intended to provide information for the […]

CARLSBAD, Calif.–GenMark Diagnostics, Inc., (NASDAQ: GNMK) and Advanced Liquid Logic, Inc. (ALL) announced today that they have executed definitive agreements pursuant to which GenMark and ALL will collaborate to develop an all-digital, fully integrated in-vitro diagnostic platform bringing together ALL’s proprietary electrowetting technology and GenMark’s proprietary electrochemical detection. The agreements follow from the Heads of […]

OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) and the Medical College of Wisconsin (MCW) today announced a collaboration agreement under which Transgenomic will offer next-generation genetic testing services performed at the MCW Clinical Sequencing Program. These services will initially include Transgenomic’s NuclearMitome Test for mitochondrial disorders. Under the agreement, the MCW laboratory will become the […]

SARASOTA, Fla., — Roper Industries, Inc. (NYSE: ROP) today announced that it has entered into a definitive agreement to acquire Sunquest Information Systems, Inc., the leading provider of diagnostic and laboratory software solutions to healthcare providers, in an all cash transaction valued at $1.415 billion, including $25 million in cash tax benefits. Headquartered in Tucson, […]

WESTBOROUGH, Mass., — GenomeQuest Inc., a global provider of large-scale genomic software applications, today announced that its GQ-Dx genomic decision support system for the production of clinical-grade diagnostic reports from next-generation sequencing (NGS) runs now meets Health Insurance Portability and Accountability Act (HIPAA) security and privacy standards. HIPAA rules protect the privacy of individually identifiable […]

White City, OR – BioMed Diagnostics, Inc., an innovative manufacturer of microbiology devices that facilitate and enhance infectious disease diagnosis, today announced its patented InTray™ and InPouch™ product lines will now be available worldwide through a new agreement with VWR International, LLC, a global laboratory supply and distribution company with 2011 worldwide sales in excess […]

Melbourne, Australia; – Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce that the Laboratory Field Services Unit of the California Department of Public Health (CDPH) has granted a license to the Company’s Australian-based laboratory. BREVAGen™ may now be offered for sale into the State of California. Based solely on incidence rates, California […]

Washington, D.C., and Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (CDC), today announced Labs for Life, a new collaboration to […]

SUNNYVALE,Calif., –Cepheid (NASDAQ: CPHD) today announced the release of an updated Xpert BCR-ABL Monitor test, now incorporating lot-specific standardization using the WHO (World Health Organization) BCR-ABL standards. The test is being released as a European CE-IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test, which runs on Cepheid’s GeneXpert […]

CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-stage patients at high risk for progression to late-stage disease. Lung cancer is currently the leading cause of cancer deaths worldwide, claiming close to 1.5 […]